Addressing the Rejection of a Rebuttal Letter: Author's Experience and Thoughts.
作者信息
Hagiya Hideharu
机构信息
Department of Infectious Diseases, Okayama University Hospital, Okayama, Japan.
出版信息
JMA J. 2024 Oct 15;7(4):628-629. doi: 10.31662/jmaj.2024-0102. Epub 2024 Sep 6.
Abstract
摘要
相似文献
1
Addressing the Rejection of a Rebuttal Letter: Author's Experience and Thoughts.应对对反驳信的拒稿：作者的经历与思考。
JMA J. 2024 Oct 15;7(4):628-629. doi: 10.31662/jmaj.2024-0102. Epub 2024 Sep 6.
2
Emergency Physicians' Rebuttal of Author's Response.急诊医师对作者回复的反驳。
Ann Emerg Med. 2017 Dec;70(6):867-870. doi: 10.1016/j.annemergmed.2017.08.011. Epub 2017 Sep 19.
3
Author's Rebuttal.作者的反驳。
Int J Angiol. 2019 Dec;28(4):274. doi: 10.1055/s-0039-1695782. Epub 2019 Sep 21.
4
Author's Rebuttal.作者的反驳。
Klin Monbl Augenheilkd. 2021 Jul;238(7):828. doi: 10.1055/a-1527-2196. Epub 2021 Aug 10.
5
Author's Rebuttal.作者的反驳。
Int J Angiol. 2019 Jun;28(2):e2. doi: 10.1055/s-0039-1679873. Epub 2019 Mar 2.
6
Author's Rebuttal to Smits et al. (2018), "Comment on 'Sensitivity of the Speech Intelligibility Index to the Assumed Dynamic Range' by Jin et al. (2017)".
J Speech Lang Hear Res. 2018 Jan 22;61(1):189-190. doi: 10.1044/2017_JSLHR-H-17-0359.
7
Author's reply: Letter to the Editor: Double counting due to inadequate statistics leads to false-positive findings in "Effects of creatine supplementation on memory in healthy individuals: a systematic review and meta-analysis of randomized controlled trials".作者回复：致编辑的信：在“补充肌酸对健康个体记忆的影响：随机对照试验的系统评价和荟萃分析”中，由于统计不足导致的重复计算会产生假阳性结果。
Nutr Rev. 2023 Oct 10;81(11):1497-1500. doi: 10.1093/nutrit/nuac111.
8
Response to letter to the editor from Dr Rahman Shiri: The challenging topic of suicide across occupational groups.回复拉赫曼·希里博士的来信：职业群体中的自杀这一具有挑战性的话题。
Scand J Work Environ Health. 2018 Jan 1;44(1):108-110. doi: 10.5271/sjweh.3698. Epub 2017 Dec 8.
9
Traps and pitfalls in evaluating a meta-analysis: rebuttal to the letter by Szczesniak et al.评估荟萃分析中的陷阱与误区：对斯切斯尼亚克等人来信的回应
Eur J Prev Cardiol. 2013 Jun;20(3):514-5. doi: 10.1177/2047487313485514. Epub 2013 Apr 9.
10
Authors' rebuttal to Integrated Risk Information System (IRIS) response to "Assessing risk of bias in human environmental epidemiology studies using three tools: different conclusions from different tools".作者对综合风险信息系统（IRIS）针对《使用三种工具评估人类环境流行病学研究中的偏倚风险：不同工具得出不同结论》的回复的反驳。
Syst Rev. 2022 Mar 23;11(1):53. doi: 10.1186/s13643-022-01894-8.
本文引用的文献
1
Comparison of clinical efficacy and safety of baloxavir marboxil versus oseltamivir as the treatment for influenza virus infections: A systematic review and meta-analysis.玛巴洛沙韦与奥司他韦治疗流感病毒感染的临床疗效和安全性比较：一项系统评价和荟萃分析
J Infect Chemother. 2024 Mar;30(3):242-249. doi: 10.1016/j.jiac.2023.10.017. Epub 2023 Oct 20.
2
Impact of Baloxavir Resistance-Associated Substitutions on Influenza Virus Growth and Drug Susceptibility.耐药相关替换对流感病毒生长和药物敏感性的影响。
J Virol. 2023 Jul 27;97(7):e0015423. doi: 10.1128/jvi.00154-23. Epub 2023 Jul 5.
3
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明：系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
4
Influenza A variants with reduced susceptibility to baloxavir isolated from Japanese patients are fit and transmit through respiratory droplets.从日本患者中分离出的对巴洛沙韦敏感性降低的甲型流感病毒变异株具有适应性，可通过呼吸道飞沫传播。
Nat Microbiol. 2020 Jan;5(1):27-33. doi: 10.1038/s41564-019-0609-0. Epub 2019 Nov 25.
5
[Recommendations for the conduct, reporting, editing and publication of scholarly work in medical journals].[关于医学期刊中学术作品的撰写、报告、编辑及发表的建议]
Zhonghua Gan Zang Bing Za Zhi. 2014 Oct;22(10):781-91.
Zotero 插件